ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Tada21c,REGN10933,S:19del,Table 1,Pseudovirus (HIV),IC50,3.9,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:19del,Table 1,Pseudovirus (HIV),IC50,13.9,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:19del,Table 1,Pseudovirus (HIV),IC50,3.7,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:614G,Table 1,Pseudovirus (HIV),IC50,3.2,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:614G,Table 1,Pseudovirus (HIV),IC50,50.3,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:614G,Table 1,Pseudovirus (HIV),IC50,8.1,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,B.1.351 Spike,Table 1,Pseudovirus (HIV),IC50,424.6,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,B.1.351 Spike,Table 1,Pseudovirus (HIV),IC50,73.5,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,B.1.351 Spike,Table 1,Pseudovirus (HIV),IC50,14.6,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,B.1.617 Spike,Table 1,Pseudovirus (HIV),IC50,78.8,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,B.1.617 Spike,Table 1,Pseudovirus (HIV),IC50,151.7,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,B.1.617 Spike,Table 1,Pseudovirus (HIV),IC50,55.3,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:19R+142D+156del+157del+158G+452R+478K+614G+681R+950N,Table 1,Pseudovirus (HIV),IC50,62.1,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:19R+142D+156del+157del+158G+452R+478K+614G+681R+950N,Table 1,Pseudovirus (HIV),IC50,28.2,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:19R+142D+156del+157del+158G+452R+478K+614G+681R+950N,Table 1,Pseudovirus (HIV),IC50,20.1,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:145del+146del+484K+614G,Table 1,Pseudovirus (HIV),IC50,139.8,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:145del+146del+484K+614G,Table 1,Pseudovirus (HIV),IC50,31.4,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:145del+146del+484K+614G,Table 1,Pseudovirus (HIV),IC50,121.8,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:440K+614G,Table 1,Pseudovirus (HIV),IC50,1.4,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:440K+614G,Table 1,Pseudovirus (HIV),IC50,1.4,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:440K+614G,Table 1,Pseudovirus (HIV),IC50,3.4,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:452R,Supplemental Figure 2D,Pseudovirus (HIV),IC50,30.7,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:452R,Supplemental Figure 2D,Pseudovirus (HIV),IC50,147.6,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:452R,Supplemental Figure 2D,Pseudovirus (HIV),IC50,25.9,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:484Q,Supplemental Figure 2D,Pseudovirus (HIV),IC50,82.3,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:484Q,Supplemental Figure 2D,Pseudovirus (HIV),IC50,53.6,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:484Q,Supplemental Figure 2D,Pseudovirus (HIV),IC50,9.9,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:681R,Supplemental Figure 2D,Pseudovirus (HIV),IC50,3.7,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:681R,Supplemental Figure 2D,Pseudovirus (HIV),IC50,43.6,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:681R,Supplemental Figure 2D,Pseudovirus (HIV),IC50,6.9,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:145del+146del,Supplemental Figure 2D,Pseudovirus (HIV),IC50,2.5,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:145del+146del,Supplemental Figure 2D,Pseudovirus (HIV),IC50,65.9,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:145del+146del,Supplemental Figure 2D,Pseudovirus (HIV),IC50,2.9,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10933,S:484K,Supplemental Figure 2D,Pseudovirus (HIV),IC50,69.3,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN10987,S:484K,Supplemental Figure 2D,Pseudovirus (HIV),IC50,39.6,1,50000,1,ng/ml,2022-08-16
Tada21c,REGN-COV2,S:484K,Supplemental Figure 2D,Pseudovirus (HIV),IC50,3.4,1,50000,1,ng/ml,2022-08-16
Tada21c,CP,S:19del,Figure 1D,Pseudovirus (HIV),NT50,321,10,600,1,NULL,2022-08-16
Tada21c,CP,S:614G,Figure 1D,Pseudovirus (HIV),NT50,284,10,600,1,NULL,2022-08-16
Tada21c,CP,B.1.1.7 Spike,Figure 1D,Pseudovirus (HIV),NT50,221,10,600,1,NULL,2022-08-16
Tada21c,CP,B.1.351 Spike,Figure 1D,Pseudovirus (HIV),NT50,74,10,600,1,NULL,2022-08-16
Tada21c,CP,B.1.617 Spike,Figure 1D,Pseudovirus (HIV),NT50,59,10,600,1,NULL,2022-08-16
Tada21c,CP,B.1.617.1 Spike,Figure 1D,Pseudovirus (HIV),NT50,87,10,600,1,NULL,2022-08-16
Tada21c,CP,S:19R+142D+156del+157del+158G+452R+478K+614G+681R+950N,Figure 1D,Pseudovirus (HIV),NT50,100,10,600,1,NULL,2022-08-16
Tada21c,CP,S:145del+146del+484K+614G,Figure 1D,Pseudovirus (HIV),NT50,93,10,600,1,NULL,2022-08-16
Tada21c,CP,S:440K+614G,Figure 1D,Pseudovirus (HIV),NT50,231,10,600,1,NULL,2022-08-16
Tada21c,BNT162b2,S:19del,Figure 1E,Pseudovirus (HIV),NT50,1098,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:614G,Figure 1E,Pseudovirus (HIV),NT50,141,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,B.1.1.7 Spike,Figure 1E,Pseudovirus (HIV),NT50,108,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,B.1.351 Spike,Figure 1E,Pseudovirus (HIV),NT50,30,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,B.1.617 Spike,Figure 1E,Pseudovirus (HIV),NT50,30,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,B.1.617.1 Spike,Figure 1E,Pseudovirus (HIV),NT50,33,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:19R+142D+156del+157del+158G+452R+478K+614G+681R+950N,Figure 1E,Pseudovirus (HIV),NT50,23,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:145del+146del+484K+614G,Figure 1E,Pseudovirus (HIV),NT50,20,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:440K+614G,Figure 1E,Pseudovirus (HIV),NT50,108,16,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:19del,Figure 1E,Pseudovirus (HIV),NT50,1376,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:614G,Figure 1E,Pseudovirus (HIV),NT50,148,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,B.1.1.7 Spike,Figure 1E,Pseudovirus (HIV),NT50,124,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,B.1.351 Spike,Figure 1E,Pseudovirus (HIV),NT50,36,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,B.1.617 Spike,Figure 1E,Pseudovirus (HIV),NT50,29,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,B.1.617.1 Spike,Figure 1E,Pseudovirus (HIV),NT50,25,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:19R+142D+156del+157del+158G+452R+478K+614G+681R+950N,Figure 1E,Pseudovirus (HIV),NT50,34,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:145del+146del+484K+614G,Figure 1E,Pseudovirus (HIV),NT50,44,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:440K+614G,Figure 1E,Pseudovirus (HIV),NT50,176,6,3000,1,NULL,2022-08-16
Tada21c,CP,S:452R,Supplemental Figure 2A,Pseudovirus (HIV),NT50,128,10,600,1,NULL,2022-08-16
Tada21c,CP,S:484Q,Supplemental Figure 2A,Pseudovirus (HIV),NT50,110,10,600,1,NULL,2022-08-16
Tada21c,CP,S:681R,Supplemental Figure 2A,Pseudovirus (HIV),NT50,285,10,600,1,NULL,2022-08-16
Tada21c,CP,S:478K,Supplemental Figure 2A,Pseudovirus (HIV),NT50,204,10,600,1,NULL,2022-08-16
Tada21c,CP,S:145del+146del,Supplemental Figure 2A,Pseudovirus (HIV),NT50,226,10,600,1,NULL,2022-08-16
Tada21c,CP,S:484K,Supplemental Figure 2A,Pseudovirus (HIV),NT50,119,10,600,1,NULL,2022-08-16
Tada21c,BNT162b2,S:452R,Supplemental Figure 2B,Pseudovirus (HIV),NT50,267,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:484Q,Supplemental Figure 2B,Pseudovirus (HIV),NT50,297,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:681R,Supplemental Figure 2B,Pseudovirus (HIV),NT50,1095,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:478K,Supplemental Figure 2B,Pseudovirus (HIV),NT50,1061,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:145del+146del,Supplemental Figure 2B,Pseudovirus (HIV),NT50,1035,16,3000,1,NULL,2022-08-16
Tada21c,BNT162b2,S:484K,Supplemental Figure 2B,Pseudovirus (HIV),NT50,258,16,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:452R,Supplemental Figure 2C,Pseudovirus (HIV),NT50,810,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:484Q,Supplemental Figure 2C,Pseudovirus (HIV),NT50,254,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:681R,Supplemental Figure 2C,Pseudovirus (HIV),NT50,1219,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:478K,Supplemental Figure 2C,Pseudovirus (HIV),NT50,1547,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:145del+146del,Supplemental Figure 2C,Pseudovirus (HIV),NT50,1005,6,3000,1,NULL,2022-08-16
Tada21c,mRNA-1273,S:484K,Supplemental Figure 2C,Pseudovirus (HIV),NT50,216,6,3000,1,NULL,2022-08-16
